Differential activation of dopaminergic systems in rat brain basal ganglia by morphine and methamphetamine

Neuroscience

Volumn 322, Issue , 2016, Pages 164-170

  Mori, T ^a   Iwase, Y ^a   Saeki, T ^a   Iwata, N ^a   Murata, A ^a   Masukawa, D ^a   Suzuki, T ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Dopamine; GABA; Methamphetamine; Morphine

Indexed keywords

4 AMINOBUTYRIC ACID; DOPAMINE; METHAMPHETAMINE; MORPHINE; DOPAMINE RECEPTOR STIMULATING AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; GABAERGIC SYSTEM; MALE; NERVE CELL; NEUROCHEMISTRY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM; ANIMAL; COMPARATIVE STUDY; DRUG EFFECTS; INDWELLING CATHETER; METABOLISM; MICRODIALYSIS; MOVEMENT (PHYSIOLOGY); PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT;

ANIMALS; BASAL GANGLIA; CATHETERS, INDWELLING; DOPAMINE; DOPAMINE AGENTS; GAMMA-AMINOBUTYRIC ACID; MALE; METHAMPHETAMINE; MICRODIALYSIS; MORPHINE; MOVEMENT; NEURONS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; VENTRAL TEGMENTAL AREA;

EID: 84959321004     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2016.01.043     Document Type: Article

References (25)

1. Barrot M., Sesack S.R., Georges F., Pistis M., Hong S., Jhou T.C. Braking dopamine systems: a new GABA master structure for mesolimbic and nigrostriatal functions. J Neurosci 2012, 32:14094-14101.
2. Blandini F., Armentero M.T. Animal models of Parkinson's disease. FEBS J 2012, 279:1156-1166.
3. Carr G.D., White N.M. Effects of systemic and intracranial amphetamine injections on behavior in the open field: a detailed analysis. Pharmacol Biochem Behav 1987, 27:113-122.
4. Celada P., Paladini C.A., Tepper J.M. GABAergic control of rat substantia nigra dopaminergic neurons: role of globus pallidus and substantia nigra pars reticulata. Neuroscience 1999, 89:813-825.
5. Chowdhury M.M., Board R. Morphine-induced hallucinations - resolution with switching to oxycodone: a case report and review of the literature. Cases J 2009, 2:9391.
6. Delfs J.M., Schreiber L., Kelley A.E. Microinjection of cocaine into the nucleus accumbens elicits locomotor activation in the rat. J Neurosci 1990, 10:303-310.
7. Funada M., Suzuki T., Narita M., Misawa M., Nagase H. Blockade of morphine reward through the activation of kappa-opioid receptors in mice. Neuropharmacology 1993, 32:1315-1323.
8. Grant K.M., LeVan T.D., Wells S.M., Li M., Stoltenberg S.F., Gendelman H.E., Carlo G., Bevins R.A. Methamphetamine-associated psychosis. J Neuroimmune Pharmacol 2012, 7:113-139.
9. Ito S., Mori T., Namiki M., Suzuki T., Sawaguchi T. Complicated interaction between psychostimulants and morphine in expression of phenotype of behavior in the dopaminergic system of BALB/c mice. J Pharmacol Sci 2007, 105:326-333.
10. Jalabert M., Bourdy R., Courtin J., Veinante P., Manzoni O.J., Barrot M., Georges F. Neuronal circuits underlying acute morphine action on dopamine neurons. Proc Natl Acad Sci U S A 2011, 108:16446-16450.
11. Johnson S.W., North R.A. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 1992, 12:483-488.
12. Joyce E.M., Iversen S.D. The effect of morphine applied locally to mesencephalic dopamine cell bodies on spontaneous motor activity in the rat. Neurosci Lett 1979, 14:207-212.
13. Klitenick M.A., DeWitte P., Kalivas P.W. Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study. J Neurosci 1992, 12:2623-2632.
14. Lee C.R., Tepper J.M. A calcium-activated nonselective cation conductance underlies the plateau potential in rat substantia nigra GABAergic neurons. J Neurosci 2007, 27:6531-6541.
15. Madhavan A., Bonci A., Whistler J.L. Opioid-induced GABA potentiation after chronic morphine attenuates the rewarding effects of opioids in the ventral tegmental area. J Neurosci 2010, 30:14029-14035.
16. Mansour A., Fox C.A., Akil H., Watson S.J. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci 1995, 18:22-29.
17. Mori T., Ito S., Kita T., Sawaguchi T. Effects of dopamine- and serotonin-related compounds on methamphetamine-induced self-injurious behavior in mice. J Pharmacol Sci 2004, 96:459-464.
18. Mori T., Ito S., Narita M., Suzuki T., Sawaguchi T. Combined effects of psychostimulants and morphine on locomotor activity in mice. J Pharmacol Sci 2004, 96:450-458.
19. Morikawa H., Paladini C.A. Dynamic regulation of midbrain dopamine neuron activity: intrinsic, synaptic, and plasticity mechanisms. Neuroscience 2011, 198:95-111.
20. Nakatani Y., Hara T. Disturbance of consciousness due to methamphetamine abuse. A study of 2 patients. Psychopathology 1998, 31:131-137.
21. Narita M., Nagumo Y., Hashimoto S., Narita M., Khotib J., Miyatake M., Sakurai T., Yanagisawa M., Nakamachi T., Shioda S., Suzuki T. Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. J Neurosci 2006, 26:398-405.
22. Ross D.D., Alexander C.S. Management of common symptoms in terminally ill patients: part II. Constipation, delirium and dyspnea. Am Fam Physician 2001, 64:1019-1026.
23. Salamone J.D., Correa M. The mysterious motivational functions of mesolimbic dopamine. Neuron 2012, 76:470-485.
24. Segal D.S., Kuczenski R. Behavioral alterations induced by an escalating dose-binge pattern of cocaine administration. Behav Brain Res 1997, 88:251-260.
25. Swanson C.J., Heath S., Stratford T.R., Kelley A.E. Differential behavioral responses to dopaminergic stimulation of nucleus accumbens subregions in the rat. Pharmacol Biochem Behav 1997, 58:933-945.